Other studies have shown that AMN and PMP tumors have low frequency mutations in SMAD4, ATM, PIK3CA, AKT and JAK3. We also identified heterogeneity in gene signature expression within the same tumor and at different metastatic sites in the same PMP patient. This evidence concerns the gene JAK3 and neoplasm.